Document:

<PAGE>

                                                                   EXHIBIT 10.36

May 10, 2005

Rosemary Mazanet, MDPhD

Dear Dr. Mazanet:

      We are pleased to extend you an offer of employment with Access
Pharmaceuticals, Inc. (the "Company") under the terms specified below:

1.    The title of your position will be Acting Chief Executive Officer and you
      will report directly to, and be subject to the direction of, the Company's
      Board of Directors. Your duties will be commensurate with the position of
      Chief Executive Officer.

2.    Your employment with the Company will be on an at-will basis, which means
      that it will not be for a definite period of time but it will be for no
      less than 3 months, and no more than 6 months without renegotiation of
      this contract. This agreement may be terminated with 30 days written
      notice at any time by either you or the Company for any reason. .

3.    Your employment with the Company will be on a full-time basis, although
      you may pursue other previously existing business activities during your
      employment that are not competitive with the Company. You will be expected
      to periodically work at the Company's offices in Dallas, Texas at the
      mutual agreement of you and the Board of Directors. You will begin your
      employment on May 11, 2005 (your "Start Date").

4.    Your compensation will consist of the following:

      a.    Your salary will be payable at a weekly rate of $$7,500 for the
            duration of this agreement.

      b.    You will be granted a non-qualified option (the "Option") of 30,000
            shares of the Company's common stock with an exercise price equal to
            the last sale price on AMEX for the Company's shares on your Start
            Date. The Option will vest monthly over a six (6) month period
            regardless of your remaining employed by the Company. Such options
            shall remain exercisable for one year after the termination of your
            employment and would be subject to the standard terms of the
            Company's stock option plan and stock option agreement except that
            such options shall vest immediately prior to a change of control
            event.

<PAGE>

      c.    As an employee of the Company, to the extent that you are not
            otherwise covered by a similar benefit, you will be eligible for the
            benefits similar to that of the Company's executive officers.

      d.    sign on bonus of $30,000 to compensate for lost consulting wages
            during this time.

      e.    D and O insurance + tail coverage will be provided.

      f.    The Company will pay or reimburse you for all reasonable expenses
            incurred or paid by you in the performance of your duties hereunder,
            upon presentation of expense statements or vouchers and such other
            information as the Company may require and according to the
            generally applicable policies and procedures of the Company.

      g.    Upon mutual agreement, you and the Board will set milestones which
            would result in the issuance of additional stock options to you.

5.    You will maintain the confidentiality of and not use or disclose except
      for Company purposes any information relating to the business or affairs
      of the Company, including any activities being or proposed to be
      undertaken by or on behalf of the Company and including any trade secrets,
      drawing, designs, information regarding product development or testing,
      business plans, financial plans, financial records and other financial,
      commercial, business or technical information of the Company or of those
      belonging to others who do business with the Company that is confidential
      or proprietary, except that you may disclose such information (i) to the
      extent required by any applicable law, - regulation or court order or
      subpoena in which case you will notify the Company as promptly as
      practicable and shall fully cooperate with the Company in its efforts, if
      any, to obtain confidential treatment of such information or limit the
      scope of information to be disclosed, (ii) to your legal counsel, (iii)
      with the prior written consent of the Company, or (iv) that has become
      generally known to the public, other than by reason of your breach of this
      paragraph.

6.    This letter contains all of the terms of the Company's offer to you. You
      acknowledge that you are not relying on any other statements, documents or
      representations you believe were made to you on behalf of the Company.

<PAGE>

      We are excited about the prospect of you joining Access Pharmaceuticals,
Inc. If this offer is acceptable to you, please sign and return one duplicate
original of this letter to me by fax. I and the other members of the Board of
Directors look forward to working with you.

Sincerely,

/s/ Michael Flinn
---------------------------------------
Michael Flinn
Chairman of the Board of Directors

ACCEPTED:

/s/ Rosemary Mazanet
---------------------------------------
Rosemary Mazanet<PAGE>
                                                                    Exhibit 10.1

                                                       PERSONAL AND CONFIDENTIAL

                            PAYLESS SHOESOURCE, INC.
                              3231 EAST 6TH AVENUE
                                  P.O. BOX 1189
                            TOPEKA, KANSAS 66601-1189
                                 (785) 233-5171
                                EXECUTIVE OFFICES

Jay A. Lentz, PhD.
Senior Vice President
   Human Resources

                                                   May 26, 2005

Steven J. Douglass
3231 SE Sixth Avenue
Topeka, Kansas 66607

Dear Steven:

              In connection with the CEO succession plan, you and Payless
ShoeSource, Inc. (the "Company") mutually agree that the last day of your
employment will be the day immediately preceding the date on which your
successor commences employment with the Company (your "Separation Date"). The
Company expects that the new CEO will commence employment on or before August 1,
2005. For the avoidance of doubt, until your Separation Date you will continue
to have the position, authority, duties and responsibilities contemplated by
Paragraph 1 of your Employment Agreement dated October 1, 2003 (your "Employment
Agreement").

              Upon your separation on the Separation Date, the Company agrees
that you will be treated for all purposes as having your employment terminated
during the Contract Term by you for Good Reason and the Company will honor all
of its obligations under your Employment Agreement.

              Unless the Company waives this requirement, your separation from
the Company will constitute your resignation from (1) any director, officer or
employee position you then have with the Company, its subsidiaries and its
affiliates and (2) all fiduciary positions (including as trustee) you hold with
respect to any pension plans or trusts established by the Company, its
subsidiaries and its affiliates. The Company and you agree that this letter will
serve as your written notice of resignation in this circumstance.

                                                     Very truly yours,

                                                     /s/ Jay Lentz

Accepted and agreed to as of the 26th day of May, 2005:

/s/ Steven J. Douglass
-----------------------------------------
          Steven J. Douglass<PAGE>
                                                                    EXHIBIT 10.1

                                                    as of May 20, 2005

UNIVERSAL AUTOMOTIVE, INC.
UNIVERSAL AUTOMOTIVE OF VIRGINIA, INC.
UNIVERSAL BRAKE PARTS, INC..
THE AUTOMOTIVE COMMODITY CONNECTION, INC.
c/o Universal Automotive Industries, Inc.
11859 South Central Avenue
Alsip, Illinois 60803

         Re:   Second Amendment to Forbearance and Amendment Agreement

Ladies and Gentlemen:

     We refer to that certain (a) Loan and Security Agreement, dated as of
January 9, 2004 (as the same now exists or may hereafter be further amended,
modified, supplemented, extended, renewed, restated or replaced, the "Loan
Agreement") by and among Wachovia Capital Finance Corporation (Central),
formerly known as Congress Financial Corporation (Central), as Agent ("Agent"),
the other Lenders from time to time party thereto ("Lenders"), and Universal
Automotive, Inc. ("Universal"), Universal Automotive of Virginia, Inc.
("Virginia"). Universal Brake Parts, Inc. ("Brake Parts") and The Automotive
Commodity Connection, Inc. ("Connection", and together with Universal, Virginia
and Brake Parts, each individually a "Borrower" and collectively, "Borrowers"):
and (b) the letter re. Forbearance and Amendment Agreement dated as of April 11,
2005 among Borrowers, Lender and Agent, as amended by the Letter re: Amendment
to Forbearance and Amendment Agreement dated as of May 12, 2005 (the
"Forbearance Agreement"). All capitalized terms used herein shall have the
meaning assigned thereto in the Forbearance Agreement, unless otherwise defined
herein.

     Borrowers have advised Agent and Lenders that Borrowers may be unable to
consummate an Approved Sale by the end of the Forbearance Period and have
requested that Agent and Lenders (a) continue to forbear for a limited period of
time from exercising their rights and remedies with respect to the Existing
Defaults, and (b) continue to make additional Loans to the Borrowers during such
limited forbearance period, and Agent and Lenders are willing to agree to the
foregoing, on and subject to the terms and conditions set forth in this letter
agreement (this "Amendment").

     In consideration of the premises and the respective agreements, covenants
and warranties contained herein, the parties hereto hereby agree, covenant and
warrant as follows:

     1. Amendment to Forbearance Period.

                  (a) Notwithstanding anything to the contrary contained in the
Forbearance Agreement, at Borrowers' request and in reliance upon Borrowers'
representations, warranties and covenants contained in this Amendment, and
subject to the terms and conditions of this

<PAGE>

Amendment, Agent and Lenders hereby agree to forbear during the Revised
Forbearance Period (as defined below) from exercising any of Agent's and
Lenders' rights and remedies with respect to the Existing Defaults, whether
arising under the Loan Agreement, the other Financing Agreements or applicable
law. For the purposes of this Amendment, the "Revised Forbearance Period" means
the period commencing on the effective date of this Amendment and terminating on
the earlier to occur of (i) May 27, 2005, and (ii) the date on which any one or
more of the following events has occurred and is continuing (hereinafter
referred to as an "Additional Event of Default"): (A) Borrowers' failure to
perform or observe any of the terms and conditions of this Amendment, (B)
Borrowers' failure to deliver to Agent, by 5:00 P.M. on May 23, 2005, a
resolution by the Board of Directors of the Borrowers (in form and substance
satisfactory to the Borrowers and the Agent and Lenders): (1) authorizing the
Borrowers to obtain from a person or persons (the "Third Party Investor") loans
(subordinated to the obligations of Agent and Lenders), a cash equity capital
contribution, or the sale of the Borrowers' capital stock or equity, or the
assets of the Borrowers to such Third Party Investor, and (2) in the event that
the Borrowers are unable to obtain a commitment letter by May 26, 2005 from a
Third Party Investor, authorizing the immediate commencement of the orderly
winding down of the Borrowers' business operations and the liquidation of the
Borrowers' assets and further authorizing the Borrowers to fully cooperate with
Agent and Lenders in connection therewith, or (C) the commencement of any
enforcement actions against the Borrowers by Laurus Master Fund, Ltd. seeking
equitable relief, or (D) the occurrence of any Event of Default under the Loan
Agreement that is not an Existing Default.

                  (b) During the Revised Forbearance Period, notwithstanding the
existence of the Existing Defaults, at Borrowers' request and as an
accommodation to Borrowers, Agent and Lenders agree to continue making Loans to
Borrowers, except that, notwithstanding anything to the contrary contained in
the Loan Agreement, the aggregate amount of Revolving Loans and Letter of Credit
Accommodations outstanding shall not exceed, at any given time, $14,000,000 in
the aggregate and the aggregate principal amount of Loans and Letter of Credit
Accommodations outstanding to a Borrower shall not exceed the Borrowing Base of
such Borrower or the Revolving Loan Limit of such Borrower.

                  (c) From and after termination or expiration of the Revised
Forbearance Period (the "Forbearance Termination Date"), the agreement of Agent
and Lenders to forbear shall automatically and without further notice or action
terminate and be of no further force and effect, and Agent and Lenders shall
have the immediate and unconditional right, in their discretion, to exercise any
or all of their rights and remedies under the Loan Agreement, the other
Financing Agreements and applicable law with respect to the Existing Defaults,
any other Event of Default which may be continuing on the date hereof or any
Additional Default or any Event of Default which may occur after the date
hereof, including, without limitation, the election by Agent and Lenders to
cease making, in their sole discretion, any further Loans and/or to enforce
their security interests in and liens upon the Collateral or any portion
thereof. Agent and Lenders have not waived any of such rights or remedies, and
nothing in this Amendment, nor the making of any Loans from and after the date
hereof or after the Forbearance Termination Date, nor any delay on the part of
Agent and Lenders after the Forbearance Termination Date in exercising any such
rights or remedies, should be construed as a waiver of any such rights or
remedies.

                                       2

<PAGE>

                  (d) Notwithstanding anything to the contrary contained in this
Amendment, (i) this Amendment does not constitute the agreement or commitment by
Agent and Lenders to make any additional Loans or provide any other credit
accommodations to Borrowers from and after the Forbearance Termination Date, and
all Loans made or other credit accommodations provided by Agent and Lenders from
and after the Forbearance Termination Date shall be made in the sole and
exclusive discretion of Agent and Lenders, and (ii) nothing contained in this
Amendment shall limit, impair or affect the rights of Agent and Lenders under
the Loan Agreement with respect to the making of Loans (including, without
limitation, the right to establish and withhold Reserves in accordance with the
Loan Agreement).

     2. Retention of Financial Advisors: Payment of Success Fee. In order to
induce Agent and Lenders to enter into this Amendment, make Loans and other
financial accommodations to Borrowers during the Forbearance Period subject to
the terms and conditions set forth in this Amendment, and forbear during the
Forbearance Period from exercising the rights and remedies of Agent and Lenders
with respect to the Existing Defaults, Borrowers have retained The Parkland
Group ("Parkland") to serve as their financial consultant. In consideration of
the services being performed by Parkland, Agent and Lenders hereby agree to
permit Parkland to receive a fee (the "Success Fee") and, under circumstances
described in the last sub-paragraph of this Section 2 below, Agent and Lenders
agree to pay the Success Fee. The Success Fee shall be earned if Parkland is
entitled to receive a success fee under the terms of its agreement with the
Borrowers, but the amount of the Success Fee payable by Agent and the Lenders
hereunder shall be as follows:

                  (a) if, after payment in full of all Post Determination Date
Obligations (as defined below), Agent and Lenders receive greater than 80% but
less than 85% of the principal Obligations outstanding as of the Debt
Determination Date (the "Debt Determination Date Obligations"), the Success Fee
shall be 1% of the Debt Determination Date Obligations;

                  (b) if, after payment in full of all Post Determination Date
Obligations, Agent and Lenders receive greater than 85% but less than 90% of the
Debt Determination Date Obligations, the Success Fee shall be 1.25% of the Debt
Determination Date Obligations;

                  (c) if, after payment in full of all Post Determination Date
Obligations, Agent and Lenders receive greater than 90% but less than 95% of the
Debt Determination Date Obligations, the Success Fee shall be 1.5% of the Debt
Determination Date Obligations;

                  (d) if, after payment in full of all Post Determination Date
Obligations, Agent and Lenders receive greater than 95% but less than 100% of
the Debt Determination Date Obligations, the Success Fee shall be 2% of the Debt
Determination Date Obligations, and

                  (e) if, after payment in full of all Post Determination Date
Obligations, Agent and Lenders receive 100% of the Debt Determination Date
Obligations, the Success Fee shall be 3.5% of the Debt Determination Date
Obligations.

     As used in this Section 2, (i) "Debt Determination Date" shall mean the
earlier to occur of (A) the consummation of the Approved Sale or (B) the date
that an orderly liquidation of the Borrowers on terms and conditions acceptable
to Agent and Lenders is commenced, or (C) the

                                       3

<PAGE>

commencement of a case under the Bankruptcy Code; and (ii) "Post Determination
Date Obligations" shall mean all accrued Obligations (other than principal
Obligation) outstanding on the Debt Determination Date and all Obligations
accruing after the Debt Determination Date.

     All fees and expenses of Parkland shall be solely the responsibility of
Borrowers and in no event shall Agent or Lenders have any liability or
responsibility for the payment of any such fees or expenses, nor shall Agent or
Lenders have any obligation or liability to Borrowers or any other person by
reason of any acts or omissions of Parkland or the sharing or disclosure of any
information with Parkland, provided, however, that Agent and Lenders will pay to
Parkland the Success Fee to the extent payable in accordance with the terms of
this Section 2 if Borrowers do not make such payment at the time earned by
Parkland under its retention agreement with the Borrowers. The payment of the
Success Fee by Agent and Lenders shall constitute an Obligation of the Borrowers
under the Loan Agreement, the amount of such payment shall be deducted from the
Debt Determination Date Obligations for the purposes of calculating the amount
of the Success Fee payable to Parkland, and the payment of the Success Fee to
Parkland shall be further subject to any order of a court of competent
jurisdiction relating thereto.

     3. Miscellaneous.. Notwithstanding anything to the contrary contained in
Section 8 of the Forbearance Agreement, nothing contained in Section 8 of the
Forbearance Agreement shall release or be deemed to release any shareholder of
Wachovia Bank, National Association from any Claims which Releasor has or may
have against any such shareholder of Wachovia Bank, National Association for any
Claim which does not arise on account of, or in relation to, or in any way in
connection with the Loan Agreement or any of the other Financing Agreements, as
amended and supplemented through the date hereof.

     4. Effect of this Amendment. Except as modified pursuant hereto, no other
changes or modifications to the Forbearance Agreement and the Financing
Agreements are intended or implied and in all other respects the Forbearance
Agreement and the Financing Agreements are hereby specifically ratified,
restated and confirmed by all parties hereto as of the effective date hereof. To
the extent of any conflict between the terms of this Amendment and the
Forbearance Agreement or any of the Financing Agreements, the terms of this
Amendment shall control. The Forbearance Agreement and this Amendment shall be
read and construed as one agreement.

     5. Governing Law; Waiver of Jury Trial. The validity, interpretation and
enforcement of this Amendment in any dispute arising our of the relationship
between the parties hereto, whether in contract, tort, equity or otherwise shall
be governed by the internal laws of the State of Illinois (without giving effect
to principles of conflicts of law). Each of the parties hereto hereby waives all
right to trial by jury and any litigation relating to transactions under this
Amendment, whether sounding in contract, tort or otherwise.

     6. Binding Effect. This Amendment shall be binding upon and inure to the
benefit of each of the parties hereto and their respective successors and
assigns.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       4

<PAGE>

     7. Counterparts. This Amendment may be executed in any number of
counterparts, but all of such counterparts when executed shall together
constitute one and the same Agreement. In making proof of this Amendment, it
shall not be necessary to produce or account for more than one counterpart
thereof signed by each of the parties hereto.

                                Very truly yours,

                                WACHOVIA CAPITAL FINANCE CORPORATION
                                (CENTRAL), AS AGENT AND AS LENDER

                                By: /s/ ILLEGIBLE
                                   ---------------------------------

                                Title: DIRECTOR
                                      ------------------------------

AGREED TO:

UNIVERSAL AUTOMOTIVE, INC.
UNIVERSAL AUTOMOTIVE OF VIRGINIA, INC.
UNIVERSAL BRAKE PARTS, INC.
THE AUTOMOTIVE COMMODITY CONNECTION, INC.

By: /s/ ILLEGIBLE
   ---------------------------
Title: CFO             of each
      ------------------------

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]